The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

ResMed Inc

NYSE: RMD
Last

(U.S.) $56.79

Today's change+0.55 +0.98%
Updated December 22 4:04 PM EST. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $56.79

Today's change+0.55 +0.98%
Updated December 22 4:04 PM EST. Delayed by at least 15 minutes.

ResMed Inc Hits New 52-week High

ResMed Inc closed up Monday by (U.S.)$0.55 or 0.98% to (U.S.)$56.79 and setting a new 52-week high. Over the last five days, shares have gained 6.45% and 20.62% year to date. Shares have outperformed the S&P 500 by 8.90% during the last year.

Key company metrics

  • Open(U.S.) $56.33
  • Previous close(U.S.) $56.24
  • High(U.S.) $57.00
  • Low(U.S.) $56.08
  • Bid / Ask-- / --
  • YTD % change+20.62%
  • Volume708,869
  • Average volume (10-day)1,236,989
  • Average volume (1-month)936,267
  • Average volume (3-month)1,041,904
  • 52-week range(U.S.) $41.52 to (U.S.) $57.00
  • Beta0.87
  • Trailing P/E23.36×
  • P/E 1 year forward21.90×
  • Forward PEG1.79×
  • Indicated annual dividend(U.S.) $1.12
  • Dividend yield1.97%
  • Trailing EPS(U.S.) $2.43
Updated December 22 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+22.03%

Based on its net profit margin of 22.03%, ResMed Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.25%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue380415398384
Total other revenue--------
Total revenue380415398384
Gross profit237261252249
Total cost of revenue143154146136
Total operating expense286317293279
Selling / general / administrative111122115112
Research & development30323030
Depreciation / amortization2222
Interest expense (income), net operating--------
Unusual expense (income)--6----
Other operating expenses, total--------
Operating income9598105105
Interest income (expense), net non-operating---6----
Gain (loss) on sale of assets--------
Other--------
Income before tax102107113109
Income after tax83889087
Income tax, total19192323
Net income83889087
Total adjustments to net income--------
Net income before extra. items83889087
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items83889087
Inc. avail. to common incl. extra. items83889087
Diluted net income83889087
Dilution adjustment----00
Diluted weighted average shares143143143145
Diluted EPS excluding extraordinary itemsvalue per share0.580.610.630.60
Dividends per sharevalue per share0.280.250.250.25
Diluted normalized EPSvalue per share0.580.650.630.60